Multi-omics studies have revealed that inactivating mutations in genes encoding components of this complex, particularly AT-rich interactive domain-containing protein 1A (ARID1A) and SMARCA4, are recurrent events in endometrial cancer. This evidence concerns the gene ARID1A and endometrial cancer.